Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection

Yeraz Khachatoorian(Icahn School of Medicine at Mount Sinai), Martín Cadeiras(University of California, Davis), Vahe Khachadourian(New York University), Mario C. Deng(University of California, Los Angeles), Elaine F. Reed(University of California, Los Angeles), Brendan J. Keating(NYU Langone Health), Brian Piening(Providence College), Eleanor Chang(University of California, Los Angeles), Erick R. Sernas(University of California, Davis), Alexandre C. Pereira(University of Washington)
Transplantation Reviews
November 20, 2020
10.1016/j.trre.2020.100590
Cited by 27

Related Papers

The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
A whole-slide foundation model for digital pathology from real-world data
|Nature|2024|761
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625